14-Hydroxydihydrocodeine

14-Hydroxydihydrocodeine is a semi-synthetic opioid derived from dihydrocodeine. It is structurally related to other opioids such as codeine and morphine. This compound is known for its analgesic properties and is used in the management of moderate to severe pain.
Chemical Structure and Properties[edit]
14-Hydroxydihydrocodeine is characterized by the presence of a hydroxyl group at the 14th position of the dihydrocodeine molecule. This modification enhances its binding affinity to the mu-opioid receptor, which is responsible for its analgesic effects. The chemical formula of 14-Hydroxydihydrocodeine is C18H23NO4.
Pharmacology[edit]
As an opioid, 14-Hydroxydihydrocodeine exerts its effects primarily through the mu-opioid receptor. Activation of this receptor leads to analgesia, euphoria, and respiratory depression. The drug also has some affinity for the delta-opioid receptor and kappa-opioid receptor, contributing to its overall pharmacological profile.
Medical Uses[edit]
14-Hydroxydihydrocodeine is used in the treatment of moderate to severe pain. It is often prescribed when other analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen, are insufficient. Due to its potency, it is typically reserved for cases where pain management is challenging.
Side Effects[edit]
Common side effects of 14-Hydroxydihydrocodeine include:
Serious side effects may include:
Regulation and Legal Status[edit]
The legal status of 14-Hydroxydihydrocodeine varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and addiction. It is typically available only by prescription and is subject to strict regulatory controls.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian